ALC
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Sector:
Industry:
Short Interest ():
Ethical Flags
Longest drawdown: 46 trading days
From: 2019-04-09 To: 2019-04-18
Lowest Point:
Novartis: Look To Alcon Instead
via: SeekingAlpha at 2019-04-16 05:22:20:000
Investment Summary Investors got excited over the prospect of Novartis ( NVS ) becoming a super-scale biotech company following the spin-off of their eye care device segment Alcon ( ALC ). However, the recent run-up in NVS's share price implies a strong pipeline execution and may be sub… read more...
Novartis: Look To Alcon Instead
via: SeekingAlpha at 2019-04-16 05:22:20:000
Investment Summary Investors got excited over the prospect of Novartis ( NVS ) becoming a super-scale biotech company following the spin-off of their eye care device segment Alcon ( ALC ). However, the recent run-up in NVS's share price implies a strong pipeline execution and may be sub… read more...
Novartis: Look To Alcon Instead
via: SeekingAlpha at 2019-04-16 05:22:20:000
Investment Summary Investors got excited over the prospect of Novartis ( NVS ) becoming a super-scale biotech company following the spin-off of their eye care device segment Alcon ( ALC ). However, the recent run-up in NVS's share price implies a strong pipeline execution and may be sub… read more...
Novartis: Look To Alcon Instead
via: SeekingAlpha at 2019-04-16 05:22:20:000
Investment Summary Investors got excited over the prospect of Novartis ( NVS ) becoming a super-scale biotech company following the spin-off of their eye care device segment Alcon ( ALC ). However, the recent run-up in NVS's share price implies a strong pipeline execution and may be sub… read more...
Novartis: Look To Alcon Instead
via: SeekingAlpha at 2019-04-16 05:22:20:000
Investment Summary Investors got excited over the prospect of Novartis ( NVS ) becoming a super-scale biotech company following the spin-off of their eye care device segment Alcon ( ALC ). However, the recent run-up in NVS's share price implies a strong pipeline execution and may be sub… read more...
Novartis: Look To Alcon Instead
via: SeekingAlpha at 2019-04-16 05:22:20:000
Investment Summary Investors got excited over the prospect of Novartis ( NVS ) becoming a super-scale biotech company following the spin-off of their eye care device segment Alcon ( ALC ). However, the recent run-up in NVS's share price implies a strong pipeline execution and may be sub… read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|